Neoantigen-targeted CD8+ T-cell responses with PD-1 blockade therapy

Описание к видео Neoantigen-targeted CD8+ T-cell responses with PD-1 blockade therapy

In a paper published in the journal Nature, Parker Senior Fellow Dr. Cristina Puig-Saus of the Parker Institute for Cancer Immunotherapy (PICI) Center at UCLA led research that analalyzed T-Cell responses in melanoma patients who were treated with different immune checkpoint inhibitors, and how those responses evolved over time. In this video, ISB President Dr. Jim Heath hosts a video conversation with Dr. Puig-Saus and Dr. Antoni Ribas, Director of PICI. Drs. Puig-Saus, Ribas and Heath are co-authors of the paper, and Drs. Ribas and Heath are founders and board members of PACT Pharma.

Комментарии

Информация по комментариям в разработке